Results 91 to 100 of about 57,339 (296)

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli   +17 more
wiley   +1 more source

Manifestation of non-ST elevation myocardial infarction due to hyperthyroidism in an anomalous right coronary artery

open access: yes, 2017
Vicken Zeitjian,1 Carmel Moazez,1 Mehrdad Saririan,2 David L August,3 Ranjini Roy2 1Department of Internal Medicine, 2Department of Cardiology, 3Department of Radiology, Maricopa Integrated Health System, Phoenix, AZ, USA Introduction: Anomalous origin ...
Moazez C   +4 more
core  

Risk Factors for In-Hospital Mortality in ST-Elevation Myocardial Infarction

open access: yes
Objective: In this study, we aimed to evaluate the in-hospital mortality indicators in patients presenting with ST-elevation myocardial infarction (STEMI) to our clinic and undergoing primary angioplasty.
Eftal Murat Bakırcı   +3 more
core   +1 more source

Primary angioplasty and pharmaco-invasive strategies in the treatment of ST-elevated myocardial infarction

open access: yes, 2019
The lecture is devoted to the choice of tactics and the rules of reperfusion therapy for ST-elevated myocardial infarction. Since the time of reperfusion is crucial for the survival of these patients and the preservation of a viable myocardium, proper ...
M. G. Glezer, E. I. Astashkin
core   +2 more sources

Eosinophilic myocarditis mimicking acute coronary syndrome secondary to idiopathic hypereosinophilic syndrome: a case report

open access: yesJournal of Medical Case Reports, 2010
Introduction Eosinophilic myocarditis is a rare form of myocarditis. It is characterized pathologically by diffuse or focal myocardial inflammation with eosinophilic infiltration, often in association with peripheral blood eosinophilia.
Nielsen Craig, Amini Reza
doaj   +1 more source

Cardiovascular regulation and vascular structure in prehypertension and coronary heart disease

open access: yes, 2009
The aim of this thesis was to characterize vascular structure and different aspects of cardiovascular regulation in otherwise healthy subjects with slightly elevated blood pressure and compare to healthy subjects with normotension and also investigate ...
Myredal, Anna
core  

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri   +12 more
wiley   +1 more source

Myocarditis Presenting as Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) in a Young Man: A Case Report

open access: yesActa Medica Indonesiana, 2023
Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a unique disorder that manifests as an acute myocardial infarction clinically without overt coronary arteries obstruction on angiography.
Giovanni Reynaldo   +2 more
doaj   +2 more sources

Non-ST-elevation myocardial infarction: dual etiology, twoway therapy

open access: yesCardiologia Hungarica
In regularly updated myocardial infarction guidelines, infarctions, including non-ST-elevation myocardial infarction (NSTEMI), were classified into 5 etiological groups, but not all characteristic features of NSTEMI can be explained in all groups ...
Mihály Medvegy, Nóra Medvegy
doaj   +1 more source

Home - About - Disclaimer - Privacy